Jindal Capital (530405)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 15.17% is meaningfully above ROE, indicating some operating efficiency at the capital employed level.
• Book value of ₹15.60 per share provides a tangible asset base, even if the price is far above it.
• At ₹33.63, the stock is 31% below its 52-week high, so a degree of pessimism is already reflected in the price.

Concerns

• P/E of 41.02 on a 44% profit decline makes the valuation very demanding for current earning power.
• ROE of 2.86% does not justify paying a P/B of 2.16 for a small financial services company.
• Latest quarter net profit of ₹0 Cr underscores very weak fundamental performance.
• Piotroski F-Score of 3/9 points to deteriorating financial health, and there is no dividend yield.

AI Analysis

At first glance, this is a classic 'look at the numbers' moment. Jindal Capital is a very small financial services company with a market cap of just ₹25 crore and quarterly sales of ₹1 crore. Net profit for the latest quarter is zero. No amount of storytelling can turn that into a wonderful business. Graham taught me to buy dollar bills for fifty cents, but here I am asked to pay ₹33.63 for book value of ₹15.60. That's 2.16 times book for a company earning only 2.86% on equity. For a financier, that is an unacceptable trade: you pay a premium for capital that barely earns anything. The ROCE of 15.17% sounds better, but it is not reaching the bottom line; profit growth has collapsed 44% and sales are down 19.20%. The Piotroski score of 3 out of 9 reinforces the picture of deteriorating fundamentals. There is no dividend to compensate, and promoter holding data is missing, which leaves me without a clear sense of alignment. In Buffett's language, this has no moat—a tiny financial services provider in a competitive market cannot command pricing power unless it has something special, and nothing here suggests that. The only positive is that book value exists and ROCE is positive, but valuation is not based on current earnings; it is based on hope. I do not invest in hope. I would pass until there is sustained evidence of profitability, better ROE, and honest disclosure. Any recovery from the 52-week low is possible, but as a value investor I need margin of safety, not a lottery ticket.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer